Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The POSEIDON study].
Briguori C, Napolitano G, Marenzi G. Briguori C, et al. Among authors: napolitano g. G Ital Cardiol (Rome). 2014 Jul-Aug;15(7-8):397-401. doi: 10.1714/1596.17410. G Ital Cardiol (Rome). 2014. PMID: 25174591 Clinical Trial. Italian. No abstract available.
Statins and contrast-induced acute kidney injury.
Briguori C, Napolitano G, Condorelli G. Briguori C, et al. Among authors: napolitano g. Coron Artery Dis. 2014 Nov;25(7):550-1. doi: 10.1097/MCA.0000000000000154. Coron Artery Dis. 2014. PMID: 25248137 No abstract available.
Endothelial Progenitor Cells and Percutaneous Coronary Artery Intervention : Editorial to: "Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells after Percutaneous Coronary Intervention (HIPOCRATES Study)" by A. Eisen et al.
Briguori C, Quintavalle C, Napolitano G, Condorelli G. Briguori C, et al. Among authors: napolitano g. Cardiovasc Drugs Ther. 2015 Apr;29(2):105-6. doi: 10.1007/s10557-015-6577-6. Cardiovasc Drugs Ther. 2015. PMID: 25712417 No abstract available.
Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C, D'Amore C, De Micco F, Signore N, Esposito G, Napolitano G, Focaccio A; REMEDIAL III Investigators. Briguori C, et al. Among authors: napolitano g. Catheter Cardiovasc Interv. 2020 Apr 1;95(5):895-903. doi: 10.1002/ccd.28386. Epub 2019 Jul 8. Catheter Cardiovasc Interv. 2020. PMID: 31282129
Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease.
Giordano A, Ferraro P, Corcione N, Messina S, Maresca G, Coscioni E, Avellino R, Giordano G, Peruzzi M, Marullo AGM, Napolitano G, Romano MF, Biondi-Zoccai G. Giordano A, et al. Among authors: napolitano g. Curr Vasc Pharmacol. 2017;15(3):257-264. doi: 10.2174/1570161115666170123094523. Curr Vasc Pharmacol. 2017. PMID: 28117007
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI.
Piccolo R, Calabrò P, Varricchio A, Baldi C, Napolitano G, De Simone C, Mauro C, Stabile E, Caiazzo G, Tesorio T, Boccalatte M, Tuccillo B, Bottiglieri G, Russolillo E, Di Lorenzo E, Carrara G, Cassese S, Leonardi S, Biscaglia S, Costa F, McFadden E, Heg D, Franzone A, Stefanini GG, Capodanno D, Esposito G. Piccolo R, et al. Among authors: napolitano g. Am Heart J. 2023 Nov;265:153-160. doi: 10.1016/j.ahj.2023.08.001. Epub 2023 Aug 10. Am Heart J. 2023. PMID: 37572785 Free article. Clinical Trial.
338 results